The chronic lymphocytic leukemia international prognostic index (CLL-IPI) predicts time to first treatment in early CLL: Independent Validation in a Prospective Cohort of Early Stage Patients

The chronic lymphocytic leukemia International Prognostic Index (CLL-IPI) combines 5 parameters (age, clinical stage, TP53 status [normal vs. del(17p) and/or TP53 mutation], IGHV mutational status, serum β2-microglobulin) to predict survival and time-to-first-treatment (TTFT) in CLL patients. We per...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Am J Hematol
Egile Nagusiak: Molica, Stefano, Shanafelt, Tait D., Giannarelli, Diana, Gentile, Massimo, Mirabelli, Rosanna, Cutrona, Giovanna, Levato, Luciano, Di Renzo, Nicola, Di Raimondo, Francesco, Musolino, Caterina, Angrilli, Francesco, Famà, Angelo, Recchia, Anna Grazia, Chaffee, Kari G., Neri, Antonino, Kay, Neil E., Ferrarini, Manlio, Morabito, Fortunato
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5072993/
https://ncbi.nlm.nih.gov/pubmed/27465919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24493
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak